Basics Eli Lilly & Co. Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products. IPO Date: January 2, 1990 Sector: Healthcare Industry: Pharma Market Cap: $651.91B Activated in VL: True Average Daily Range Avg Daily Range: $1.74 | 0.94% Avg Daily Range (30 D): $9.16 | 1.29% Avg Daily Range (90 D): $10.31 | 1.36% Institutional Daily Volume Avg Daily Volume: 4.36M Avg Daily Volume (30 D): 5.03M Avg Daily Volume (90 D): 3.8M Trade Size Avg Trade Size (Sh.): 121 Avg Trade Size (Sh.) (30 D): 28 Avg Trade Size (Sh.) (90 D): 27 Institutional Trades Total Inst.Trades: 86,429 Avg Inst. Trade: $9.13M Avg Inst. Trade (30 D): $67.66M Avg Inst. Trade (90 D): $70.09M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 15 Market Closing Trades Avg Closing Trade: $80.62M Avg Closing Trade (30 D): $316.11M Avg Closing Trade (90 D): $328.72M Avg Closing Volume: 413.97K     News Sep 7, 2025 @ 3:14 PM Think It's Too Late to Buy This Leading Biotech St... Source: Lee Samaha Sep 5, 2025 @ 8:29 AM 2 S&P 500 Dividend Stocks That Could Climb More Th... Source: Cory Renauer Sep 5, 2025 @ 8:10 AM Down 34%, Should You Buy the Dip on Viking Therape... Source: Adria Cimino Sep 4, 2025 @ 3:00 PM Monoclonal Antibodies Therapeutics Market Size Pro... Source: Towards Healthcare Sep 4, 2025 @ 8:25 AM Where Will Eli Lilly Be in 3 Years? Source: Adria Cimino Financials   TTM Q2 2025 Q1 2025 Basic EPS $15.35 $6.3 $3.07 Diluted EPS $15.3 $6.29 $3.06 Revenue $ 53.26B $ 15.56B $ 12.73B Gross Profit $ 44.01B $ 13.11B $ 10.5B Net Income / Loss $ 13.8B $ 5.66B $ 2.76B Operating Income / Loss $ 16.86B $ 6.78B $ 3.46B Cost of Revenue $ 9.25B $ 2.45B $ 2.22B Net Cash Flow $ 152.3M $ 282.6M $ -175.1M PE Ratio 47.48